What are the essential determinants of human papillomavirus carcinogenesis?
mBio · 2024
DOI: 10.1128/mbio.00462-24 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift mBio, 2024. Verfasst von Karl Munger und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Carcinogenesis, Papillomavirus Infections, Oncogene Proteins, Viral, Host-Pathogen Interactions. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), HHS | NIH | National Institute of Dental and Craniofacial Research (NIDCR), NCI NIH HHS.
Abstract (Originalsprache)
Human papillomavirus (HPV) infection is the leading viral cause of cancer. Over the past several decades, research on HPVs has provided remarkable insight into human cell biology and into the pathology of viral and non-viral cancers. The HPV E6 and E7 proteins engage host cellular proteins to establish an environment in infected cells that is conducive to virus replication. They rewire host cell signaling pathways to promote proliferation, inhibit differentiation, and limit cell death. The activity of the “high-risk” HPV E6 and E7 proteins is so potent that their dysregulated expression is sufficient to drive the initiation and maintenance of HPV-associated cancers. Consequently, intensive research efforts have aimed to identify the host cell targets of E6 and E7, in part with the idea that some or all of the virus-host interactions would be essential cancer drivers. These efforts have identified a large number of potential binding partners of each oncoprotein. However, over the same time period, parallel research has revealed that a relatively small number of genetic mutations drive carcinogenesis in most non-viral cancers. We therefore propose that a high-priority goal is to identify which of the many targets of E6 and E7 are critical drivers of HPV carcinogenesis. By identifying the cancer-driving targets of E6 and E7, it should be possible to better understand the distinct roles of other targets, perhaps in the viral life cycle, and to focus efforts to develop anti-cancer therapies on the subset of virus-host interactions for which therapeutic intervention would have the greatest impact.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, Massachusetts, USA.
- Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Karl Munger, Elizabeth A White
Förderung
- HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
- HHS | NIH | National Institute of Dental and Craniofacial Research (NIDCR)
- NCI NIH HHS
- NIAID NIH HHS
- NIDCR NIH HHS
- HHS | NIH | National Cancer Institute (NCI)
Zitieren
APA
Munger, K., & White, E. A. (2024). What are the essential determinants of human papillomavirus carcinogenesis?. mBio. https://doi.org/10.1128/mbio.00462-24
Vancouver
Munger K, White EA. What are the essential determinants of human papillomavirus carcinogenesis?. mBio. 2024. doi:10.1128/mbio.00462-24
BibTeX
@article{Munger2024,
author = {Munger, Karl and White, Elizabeth A},
title = {What are the essential determinants of human papillomavirus carcinogenesis?},
journal = {mBio},
year = {2024},
doi = {10.1128/mbio.00462-24}
}
EUVIMED